CN1724056A - 鲑鱼籽(大马哈鱼籽）营养保健软胶囊及其制备工艺 - Google Patents
鲑鱼籽(大马哈鱼籽）营养保健软胶囊及其制备工艺 Download PDFInfo
- Publication number
- CN1724056A CN1724056A CN 200510010104 CN200510010104A CN1724056A CN 1724056 A CN1724056 A CN 1724056A CN 200510010104 CN200510010104 CN 200510010104 CN 200510010104 A CN200510010104 A CN 200510010104A CN 1724056 A CN1724056 A CN 1724056A
- Authority
- CN
- China
- Prior art keywords
- salmon roe
- soft capsule
- oil
- health
- nutrition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 21
- 241000972773 Aulopiformes Species 0.000 title claims description 35
- 235000019515 salmon Nutrition 0.000 title claims description 35
- 235000016709 nutrition Nutrition 0.000 title claims description 15
- 230000035764 nutrition Effects 0.000 title claims description 14
- 238000000034 method Methods 0.000 title claims description 3
- 239000008280 blood Substances 0.000 claims abstract description 14
- 210000004369 blood Anatomy 0.000 claims abstract description 14
- 235000004347 Perilla Nutrition 0.000 claims abstract description 11
- 230000036039 immunity Effects 0.000 claims abstract description 11
- 238000000605 extraction Methods 0.000 claims description 19
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 13
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 11
- 241000229722 Perilla <angiosperm> Species 0.000 claims description 10
- 230000002929 anti-fatigue Effects 0.000 claims description 10
- 229930003427 Vitamin E Natural products 0.000 claims description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 9
- 238000000926 separation method Methods 0.000 claims description 9
- 229940046009 vitamin E Drugs 0.000 claims description 9
- 235000019165 vitamin E Nutrition 0.000 claims description 9
- 239000011709 vitamin E Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 6
- 239000001569 carbon dioxide Substances 0.000 claims description 6
- 238000004108 freeze drying Methods 0.000 claims description 6
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 230000018044 dehydration Effects 0.000 claims description 3
- 238000006297 dehydration reaction Methods 0.000 claims description 3
- 239000003292 glue Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- -1 antiseptic Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 230000036541 health Effects 0.000 claims description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- 108010010803 Gelatin Proteins 0.000 claims 1
- 230000002421 anti-septic effect Effects 0.000 claims 1
- 239000000284 extract Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000003605 opacifier Substances 0.000 claims 1
- 239000000049 pigment Substances 0.000 claims 1
- 239000004014 plasticizer Substances 0.000 claims 1
- 235000019197 fats Nutrition 0.000 abstract description 7
- 150000001413 amino acids Chemical class 0.000 abstract description 2
- 239000011573 trace mineral Substances 0.000 abstract description 2
- 235000013619 trace mineral Nutrition 0.000 abstract description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 abstract 1
- 244000124853 Perilla frutescens Species 0.000 abstract 1
- 241000277263 Salmo Species 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 210000001161 mammalian embryo Anatomy 0.000 abstract 1
- 230000000050 nutritive effect Effects 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010013663 drug dependence Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000011117 substance-related disease Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N linoleic acid group Chemical group C(CCCCCCC\C=C/C\C=C/CCCCC)(=O)O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种降血脂并提高机体免疫能力抗疲劳的鲑鱼籽营养保健软胶囊及其制备工艺，采用二氧化碳超临界萃取的方法，将鲑鱼籽、玉米胚芽、紫苏子等天然食物中的有效成分提取出来，制成软胶囊，含有大量的亚油酸、亚麻酸、EPA(二十碳五烯酸)和DHA(二十二碳六烯酸)等多种多烯不饱和脂肪酸、18种氨基酸、多种维生素及微量元素等营养成分，具有降血脂、提高血清中IgG水平，增加机体细胞免疫力、降低血清MDA含量，防止细胞损伤和抗疲劳等营养保健功能。
Description
技术领域
本发明涉及一种降血脂并提高机体免疫能力、抗疲劳的鲑鱼籽营养保健软胶囊及其制备工艺，属于保健食品制作技术领域。
背景技术
高血脂症易引发心、脑血管疾病，是冠心病、脑血栓的危险因素之一。近年来，高血脂症的发病率越来越高，为了从源头上抑制心、脑血管疾病的发生和发展，对于心、脑血管病患者来说，当务之急就是降低血脂、抑制心脑血管病的发生，目前在国内，大都采用药物来治疗高血脂症。这些降血脂药物，大多数都是合成药物，服用后都会产生一定的副作用，并且造成一定程度的药物依赖性。
发明内容
本发明的目的是提供一种降血脂并提高机体免疫能力抗疲劳的鲑鱼籽营养保健软胶囊及其制备工艺。
本发明是由食用软胶囊囊皮和在囊皮中内封的鲑鱼籽营养保健制剂组成。其组成和各组份的数量指标是：鲑鱼籽油600-700，玉米胚芽油800-900，紫苏子油500-600，维生素E3-5。上述鲑鱼籽油、玉米胚芽油、紫苏子油均是采用二氧化碳超临界萃取的油状液体，维生素E含量≥92％，符合《中华人民共和国药典》规定的维生素E。
上述降血脂并提高机体免疫能力抗疲劳的鲑鱼籽营养保健软胶囊的制备方法是：首先将经过筛选去除杂质的鲑鱼籽在低温冷冻干燥机(冻干机)内，在-30℃--45℃条件下，冷冻干燥30个小时，使其含水量达到7％-9％，然后将玉米胚芽、紫苏子分别在70℃-80℃的温度下干燥至含水量为7％-9％；再用粉碎机分别把干燥后的鲑鱼籽、玉米胚芽、紫苏子粉碎成80-100目的粉末，进行二氧化碳超临界萃取。
鲑鱼籽粉末的萃取条件是：萃取压力为24-32Mpa，萃取温度为32℃-38℃，一级分离压力为10.5-11.5Mpa，二级分离压力5-6Mpa，分离温度36℃-40℃。
玉米胚芽粉末的萃取条件为：萃取压力16-20Mpa，萃取温度32-36℃，一级分离压力10.5-11.5Mpa，二级分离压力5-6Mpa，分离温度38-42℃。
紫苏子粉末的萃取条件是：萃取压力为20-24Mpa，萃取温度为33℃-37℃，一级分离压力为10.5-11.5Mpa，二级分离压力5-6Mpa，分离温度38℃-42℃。
上述过程获得油状液体，分别是鲑鱼籽油、玉米胚芽油、紫苏子油。按照重量份分别称取鲑鱼籽油600-700、玉米胚芽油800-900、紫苏子油500-600另及维生素E3-5放入调配罐中，混合搅拌均匀，得到混合液。将该混合液总重量10-15％的盐水(含NaCl6％)喷洒到混合液中，加热至80℃后保持恒温6小时，进行软化脱水，得到澄清的混合油液，加热到105-110℃并保持25分钟进行干燥，直至混合油液中无气泡产生，进行灭菌处理，再将混合油液用制胶丸机制成软胶囊。软胶囊单位重量0.5g/粒或1.0g/粒。
本发明的降血脂并提高机体免疫能力抗疲劳的鲑鱼籽营养保健软胶囊由于采用了二氧化碳超临界萃取工艺提取鲑鱼籽、玉米胚芽、紫苏子等天然食物中的有效成分，不含有其他溶剂和杂质。其产品中含有大量的亚油酸、亚麻酸、EPA(二十碳五烯酸)和DHA(二十二碳六烯酸)等多种多烯不饱和脂肪酸、18种氨基酸、多种维生素及微量元素等营养成分，具有降血脂、提高血清中IgG水平，增加机体细胞免疫、降低血清MDA含量，防止细胞损伤和抗疲劳等营养保健功能。
由于本发明的主要原料都是天然食品，避免了服用后产生副作用和药物依赖性。
结合实施例，对本发明作进一步说明。
1.将经过筛选去除杂质的鲑鱼籽在低温冷冻干燥机(冻干机)内，在-30℃-45℃条件下，冷冻干燥30个小时，使其含水量达到7％-9％，然后将玉米胚芽、紫苏子分别在70℃-80℃的温度下，干燥至含水量为7％-9％；
2.用粉碎机分别把干燥后的鲑鱼籽、玉米胚芽、紫苏子粉碎成80-100目的粉末，进行二氧化碳超临界萃取，得到鲑鱼籽油、玉米胚芽油、紫苏子油。 鲑鱼籽粉磨的萃取条件是：萃取压力为24-32Mpa，萃取温度为32℃-38℃，一级分离压力为10.5-11.5Mpa，二级分离压力5-6Mpa，分离温度36℃-40℃；玉米胚芽粉末的萃取条件为：萃取压力16-20Mpa，萃取温度32-36℃，一级分离压力10.5-11.5Mpa，二级分离压力5-6Mpa，分离温度38-42℃；紫苏子粉末的萃取条件是：萃取压力为20-24Mpa，萃取温度为33℃-37℃，一级分离压力为10.5-11.5Mpa，二级分离压力5-6Mpa，分离温度38℃-42℃。
3.将鲑鱼籽油、玉米胚芽油、紫苏子油，按照重量组成分别称取鲑鱼籽油600-700、玉米胚芽油800-900、紫苏子油500-600，另外称取维生素E 3-5放入调配罐中，混合搅拌均匀，得到混合液。
4.将该混合液总重量的10-15％的含6％NaCl盐水喷洒到混合液中，加热至80℃后保持恒温6小时，进行软化脱水，得到澄清的混合油液。
5.将混合油液加热到105-110℃并保持25分钟进行干燥，直至混合油液中无气泡产生后，进行灭菌处理。
6.将混合油液用制胶丸机制成软胶囊。软胶囊单位重量0.5g/粒或1.0g/粒。
Claims (7)
1.降血脂并提高机体免疫能力抗疲劳的鲑鱼籽营养保健软胶囊是，由食用软胶囊囊皮和在食用软胶囊囊皮中内封的营养保健制剂组成。其制剂特征在于：该营养保健按制剂的组成及各组分的重量份为鲑鱼籽油600-700、玉米胚芽油800-900、紫苏子油500-600、维生素E3-5；
2.按照权利要求1提出的鲑鱼籽油、玉米胚芽油、紫苏子油均是采用二氧化碳超临界萃取方法，从鲑鱼籽、玉米胚芽、紫苏子中提取出来的油状液体，维生素E含量≥92％，符合《中华人民共和国药典》规定的维生素E；
3.按照权利要求1提出的降血脂并提高机体免疫能力抗疲劳的鲑鱼籽营养保健软胶囊的制备方法，其特征在于：鲑鱼籽在低温冷冻干燥机内-30℃--45℃条件下，冷冻干燥30个小时，使其含水量达到7％-9％，然后将玉米胚芽、紫苏子分别在70℃-80℃的温度下，干燥至含水量为7％-9％；再用粉碎机分别把干燥后的鲑鱼籽、玉米胚芽、紫苏子粉碎成80-100目的粉末，进行二氧化碳超临界萃取。
4.按照权利要求1提出的降血脂并提高机体免疫能力抗疲劳的鲑鱼籽营养保健软胶囊的制备方法，其特征在于：鲑鱼籽粉末的萃取条件是：萃取压力为24-32Mpa，萃取温度为32℃-38℃，一级分离压力为10.5-11.5Mpa，二级分离压力5-6Mpa，分离温度36℃-40℃；玉米胚芽粉末的萃取条件为：萃取压力16-20Mpa，萃取温度32-36℃，一级分离压力10.5-11.5Mpa，二级分离压力5-6Mpa，分离温度38-42℃；紫苏子粉末的萃取条件是：萃取压力为20-24Mpa，萃取温度为33℃-37℃，一级分离压力为10.5-11.5Mpa，二级分离压力5-6Mpa，分离温度38℃-42℃；
5.按照权利要求1提出的降血脂并提高机体免疫能力抗疲劳的鲑鱼籽营养保健软胶囊的制备方法，其特征在于：鲑鱼籽油、玉米胚芽油、紫苏子油、维生素E的混合液中喷洒入占混合液总重量10-15％的盐水(含NaCl6％)，并加热至80℃后保持恒温6小时，进行软化脱水，得到澄清的混合油液，加热到105-110℃并保持25分钟进行干燥灭菌处理，直至混合油液中无气泡产生，再将混合油液用制胶丸机制成软胶囊；
6.按照权利要求1提出的降血脂并提高机体免疫能力抗疲劳的鲑鱼籽营养保健软胶囊单位重量0.5g/粒或1.0g/粒；
7.按照权利要求1提出的降血脂并提高机体免疫能力抗疲劳的鲑鱼籽营养保健软胶囊囊皮是用明胶、甘油、增塑剂、防腐剂、遮光剂、色素或其它适宜的食用材料制成。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100101041A CN100500199C (zh) | 2005-06-20 | 2005-06-20 | 鲑鱼籽营养保健软胶囊 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100101041A CN100500199C (zh) | 2005-06-20 | 2005-06-20 | 鲑鱼籽营养保健软胶囊 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1724056A true CN1724056A (zh) | 2006-01-25 |
| CN100500199C CN100500199C (zh) | 2009-06-17 |
Family
ID=35923774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100101041A Expired - Fee Related CN100500199C (zh) | 2005-06-20 | 2005-06-20 | 鲑鱼籽营养保健软胶囊 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100500199C (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101664210B (zh) * | 2009-09-29 | 2012-05-23 | 山东省海洋水产研究所 | 一种海参卵营养品的加工方法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE212015000031U1 (de) * | 2014-05-13 | 2017-02-20 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Zusammensetzung, die Samenölextrakte und Phospholipide verwendet, um die Absorption von Carotinoiden zu verbessern |
-
2005
- 2005-06-20 CN CNB2005100101041A patent/CN100500199C/zh not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101664210B (zh) * | 2009-09-29 | 2012-05-23 | 山东省海洋水产研究所 | 一种海参卵营养品的加工方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100500199C (zh) | 2009-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Paul et al. | Pomegranate seed oil in food industry: Extraction, characterization, and applications | |
| CN103141712B (zh) | 一种蛋鸡产蛋期配合饲料及其制备方法 | |
| CN109645320A (zh) | 一种轻断食全营养配方可冲泡即食棒及其制备方法 | |
| CN109123643A (zh) | 一种谷物代餐球的制备方法 | |
| KR20130039309A (ko) | 마늘과 난황의 복합 활성물질를 건강개선 기능성 약효제로 포함하는 식품조성물과 그 제조방법. | |
| CN104004583B (zh) | 含亚油酸和亚麻酸的天然保健植物油及其制备方法和应用 | |
| CN103859096B (zh) | 养生茶 | |
| CN101507499B (zh) | 魔竽红苕粉 | |
| CN108477609A (zh) | 一种牛蒡减肥代餐棒及其制备方法 | |
| CN102160615A (zh) | 以牡丹提取物作为基料的保健食品组份及其应用 | |
| CN102907741A (zh) | 一种牡丹籽油口服液的制备方法 | |
| CN104920933A (zh) | 一种蜂胶软胶囊及其制备方法 | |
| CN106720469A (zh) | 一种食用调制油及其制备方法 | |
| CN1278737C (zh) | 一种具有生物活性的复方药物制剂 | |
| CN108684819A (zh) | 一种青少年果蔬乳品饮料及其制备方法 | |
| CN108813032A (zh) | 一种沙棘刺五加茶及其制作方法 | |
| CN100500199C (zh) | 鲑鱼籽营养保健软胶囊 | |
| CN1723806A (zh) | 鲑鱼白（大马哈鱼白）营养保健食品及制备工艺 | |
| KR101512230B1 (ko) | 면역력 및 혈액순환 개선 기능을 갖는 관절염 치료 조성물과 그 제조방법 | |
| CN101120750A (zh) | 银杏蜂产品的制备方法 | |
| CN107594526A (zh) | 一种海藻胶为囊材的助消化软胶囊制剂的制备方法 | |
| CN107412626A (zh) | 一种健脾祛湿组合物及其加工方法及在祛湿降尿酸产品中的应用 | |
| CN1271187C (zh) | 紫苏油保健品 | |
| KR101093006B1 (ko) | 미생물을 이용한 우황 청심원 원료 함유 건강식품의 제조방법 및 그 제조방법에 의해 제조된 건강식품 | |
| CN106135667A (zh) | 一种可替代抗生素的畜禽用风味草本植物饲料添加剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhang Xiaodong Document name: Deemed not to advise |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHANG RENJIU Free format text: FORMER OWNER: LI FUMIN Effective date: 20101015 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Renjiu Inventor before: Li Fumin |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 150090 TOWER A, 6/F, NO.233, MINJIANG ROAD, NANGANG DISTRICT, HARBIN CITY, HEILONGJIANG PROVINCE TO: 150069 NO.39, HUANGHAI ROAD, DEVELOPMENT AREA, HAPING ROAD, HARBIN CITY Free format text: CORRECT: INVENTOR; FROM: LI FUMIN TO: ZHANG RENJIU |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20101015 Address after: The Yellow Sea Road haping Road Development Zone 150069 Harbin City No. 39 Patentee after: Zhang Renjiu Address before: building 6, building 233, Minjiang Road, Nangang District, Heilongjiang, Harbin, China 150090 Patentee before: Li Fumin |
|
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Harbin Yeekong Herb Inc. Assignor: Zhang Renjiu Contract record no.: 2011230000296 Denomination of invention: Salmon roe nutrition and health-care soft capsule Granted publication date: 20090617 License type: Exclusive License Open date: 20060125 Record date: 20111026 |
|
| ASS | Succession or assignment of patent right |
Owner name: HARBIN YIKANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHANG RENJIU Effective date: 20130524 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20130524 Address after: Haping Road Development Zone in Harbin City, Heilongjiang province 150060 District Xinjiang Road No. 17 Patentee after: Harbin Yeekong Herb Inc. Address before: The Yellow Sea Road haping Road Development Zone of Heilongjiang Province, Harbin City, No. 39, 150060 Patentee before: Zhang Renjiu |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090617 Termination date: 20160620 |